Medera, Inc., (“Medera”), a clinical-stage biotechnology company, announced today that the management team will participate ...

Bruce Rapport Faculty of Medicine, Technion–Israel Institute of Technology, Haifa, Israel (I.R.H., N.K., C.B., O.C.). The Clinical Research Institute at Rambam ...

BioCardia's confirmatory Phase 3 trial of its autologous CardiAMP cell therapy product candidate for patients with ischemic heart failure of reduced ejection fraction or HFrEF. The upcoming ...

Heart disease is a term used to describe a constellation of conditions that can affect the heart and/or its valves, vessels, structure, electrical system, or coronary arteries. Though each disease ...

The intended patient population includes those with symptomatic heart failure with preserved ejection fraction (HFpEF) with left ventricular ejection fraction (LVEF) ≥60%. The primary goal ...

has seen its heart failure therapy, JK07, achieve some success in interim results taken from an ongoing Phase II trial examining its treatment in patients living with reduced ejection fraction ...

A heart surgeon has revealed the simple at-home test that could reveal the symptoms of one of Britain's biggest killers. In a clip posted to TikTok, US-based cardiothoracic surgeon Dr Jeremy ...

“By rule, if a player gets hit in the private area it's an automatic F2 and ejection for the opponent who hit the player. You can't officiate intent,” Wymer said. Northwestern head coach Chris ...

Eventually, these conditions can lead to end-stage heart failure and/or death. End-stage heart failure means that both sides of the heart fail to pump enough blood to sustain your body. A blood test ...